Reproducibility of Nerve Fiber Layer Thickness Measurements in Patients With Glaucoma and Healthy Controls Using Spectral-Domain and Time-Domain OCT

Phase 4TerminatedNCT01273285

University of Zurich50 enrolled

Overview

To assess the reproducibility of Spectral-Domain-OCT (SD-OCT) retinal nerve fiber layer thickness (RNFL) thickness measurements in healthy volunteers and patients with glaucoma and to compare these results to conventional Time-Domain-OCT (TD-OCT). * Trial with medical device

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Glaucoma Patients and Healthy Controls

Interventions

Spectralis® SD-OCT, Heidelberg Engineering GmbH, HDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: control group: age 18yo or older, healthy glaucom group: age 18yo or older, diagnosis of primary open angle glaucoma (POAG) Exclusion criteria: Exclusion criteria in the control group were history of glaucoma, history of any other ocular disease, or intraocular pressure greater than 21mmHg. Exclusion criteria in the glaucoma group were history of other optic neuropathies. or severe optic media opacities.

Locations (1)

Unnamed facility

Zurich, Switzerland

Outcomes

Primary Outcomes

reproducibility of retinal nerve fiber layer thickness measurement

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.